Overview
Cascade Tissue Group-Maryland, LLC operates a pulp and paper facility in Hagerstown, Maryland, USA. The plant is operational and produces tissue products for commercial and consumer markets.
Cascade Tissue Group-Maryland, LLC is a pulp and paper facility located at 551 Eastern Blvd., South, Hagerstown, Maryland, in Washington County. The plant is operational and specializes in the production of tissue paper products, serving both commercial and consumer markets. As part of the broader Cascade Tissue Group, this facility contributes to the company's presence in the northeastern United States. The facility operates under the regulatory framework of the United States Environmental Protection Agency (EPA), which enforces multi-media environmental regulations including the Clean Air Act (CAA), Clean Water Act (CWA), Resource Conservation and Recovery Act (RCRA), and Toxics Release Inventory (TRI) Section 313 reporting. Pulp and paper mills are subject to specific effluent guidelines and air emission standards, and this plant likely holds permits for wastewater discharge and air emissions. The facility's scale is typical for a regional tissue producer, with production lines for converting pulp into finished tissue rolls. Pulp and paper manufacturing is water-intensive and generates significant wastewater, requiring robust treatment systems. The plant's location in Hagerstown, near the Potomac River watershed, underscores the importance of compliance with water quality regulations. The facility also manages solid waste, including sludge from wastewater treatment, under RCRA guidelines. Its operational status indicates ongoing contribution to the local economy and paper product supply chain.
Environmental context
The facility is situated in Hagerstown, Maryland, within the Chesapeake Bay watershed, which is subject to stringent nutrient and sediment reduction goals under the Chesapeake Bay Total Maximum Daily Load (TMDL). Pulp and paper mills can release pollutants such as biochemical oxygen demand (BOD), total suspended solids (TSS), and chlorinated compounds. The plant's proximity to the Potomac River requires careful management of wastewater discharges to protect aquatic ecosystems. Community proximity to the industrial area may raise concerns about air emissions, including volatile organic compounds (VOCs) and particulate matter, which are regulated under the Clean Air Act.
Frequently asked questions
The facility is located at 551 Eastern Blvd., South, Hagerstown, Maryland 21740, in Washington County, USA.
The plant produces tissue paper products, including bath tissue, paper towels, and napkins, for commercial and consumer markets.
The facility must comply with US EPA regulations including the Clean Air Act, Clean Water Act, RCRA, and TRI reporting. It likely holds permits for air emissions and wastewater discharge.
Pulp and paper mills use large volumes of water and generate wastewater containing BOD, TSS, and other pollutants. Treatment systems are required to meet discharge limits under the Clean Water Act.
The facility is currently operational, indicating active production and ongoing regulatory compliance.
Other Pulp Paper plants in United States · 6 nearby